To buy shares in Rani Therapeutics Holdings Inc. Class A you will need a US based stock trading platform like Interactive Brokers or Moomoo where it currently costs $0.83 to buy one share in Rani Therapeutics Holdings Inc. Class A (as of 15:33 18-Aug-2026). Which is a change of $0 or 0.19% from the last closing price of $0.8.
How To Buy Rani Therapeutics Holdings Inc. Class A Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in Rani Therapeutics Holdings Inc. Class A:
- Pick a stock broker (jump down to compare the best brokers for buying Rani Therapeutics Holdings Inc. Class A stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:RANI)
- Choose the number of shares you want to buy (1 share currently costs $0.83)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your Rani Therapeutics Holdings Inc. Class A stock in your account (this will show your profit and loss)
[qmod detailedquotetabchart RANI:US name=”Rani Therapeutics Holdings Inc. Class A” show_profile=”1″ ticker=”RANI” heading=”h2″]
- Rani Therapeutics Holdings Inc. Class A is currently worth $115,299,213 based on the last closing price of $0.8 with 2,284,454 shares traded.
- The most recent Rani Therapeutics Holdings Inc. Class A daily high has been $0.89 and daily low $0.75.
- The Rani Therapeutics Holdings Inc. Class A stock price 52 week high has been $3.87 and the 52 week low $0.44.
Compare Brokers For Buying Rani Therapeutics Holdings Inc. Class A Stock
Is Now A Good Time To Buy Rani Therapeutics Holdings Inc. Class A Stock?
- Rani Therapeutics Holdings Inc. Class A’s EPS (earnings per share) are 0.26. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- Rani Therapeutics Holdings Inc. Class A’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below Rani Therapeutics Holdings Inc. Class A share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold. Subscribe to Good Money Guide Analysis for expert opinion on the latest investment opportunities.
[qmod analyst|earnings|financials|financialsummary|pricehistory|interactivechart|dividends|corporateevents|shareinfoperformance|fullnews|companyprofile RANI:US name=”Rani Therapeutics Holdings Inc. Class A” show_profile=”1″ ticker=”RANI” heading=”h2″]



